Equity Profile

VEEV

Veeva Systems Inc.

Health CareHealth Care Technology$32.0B

Jun3Wed

Pre-Earnings Brief

UpcomingQ1-2027After Close5:00 PM EDT

Company Snapshot

Veeva Systems Inc. is a healthcare technology company that provides cloud-based software solutions for the life sciences industry....

Key Metrics to Watch

EPS

Earnings per share is a key indicator of profitability and will show how well Veeva is managing costs and generating income.

$2.14

Revenue

Revenue growth is crucial for assessing the company's ability to expand its market share and maintain its competitive edge.

$858M

Wall Street expectations, options signals, track record, and call prep available with Pro.

VEEV Q1-2027 Earnings Preview

Context

Company Snapshot

Veeva Systems Inc. is a healthcare technology company that provides cloud-based software solutions for the life sciences industry. With a market cap of $32 billion, Veeva plays a critical role in streamlining processes for pharmaceutical and biotechnology companies, particularly in areas like customer relationship management and regulatory compliance.

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

100%

Avg EPS Surprise

+60.26%

Avg Stock Reaction

-0.51%

Last Quarter Recap

In the last quarter, Veeva reported an EPS of $2.06, significantly beating analyst expectations. The stock reacted positively, gaining 1.38% the following day.

Management Promises & Guidance

Continued focus on expanding their product offerings.
Commitment to enhancing customer experience through technology.
Plans to invest in research and development to drive innovation.

Expectations

Wall Street Expectations

Analysts are generally optimistic about Veeva's upcoming earnings, expecting solid performance based on historical trends. The consensus EPS is set at $2.14, indicating confidence in the company's ability to deliver strong results.

Bull Case

If Veeva exceeds expectations, it could signal robust demand for its products and lead to increased investor confidence, potentially driving the stock price higher.

Bear Case

Conversely, if the company fails to meet the consensus estimates, it could raise concerns about its growth trajectory and lead to a decline in stock price.

Key Metrics to Watch

EPS

$2.14

Earnings per share is a key indicator of profitability and will show how well Veeva is managing costs and generating income.

Revenue

$858M

Revenue growth is crucial for assessing the company's ability to expand its market share and maintain its competitive edge.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will Veeva's EPS exceed the consensus estimate of $2.14?

A beat on EPS would reinforce the company's strong performance trend and could lead to a positive market reaction.

What are the revenue projections for the upcoming quarters?

Revenue guidance will be crucial for understanding the company's growth trajectory and market demand.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may underestimate Veeva's ability to innovate and capture market share, especially given its strong track record of beating EPS estimates.

Supporting Evidence

Veeva has consistently exceeded EPS expectations in recent quarters, indicating strong operational performance.

The options market is pricing in a larger move than historical averages, suggesting traders expect significant volatility.

Recent trends in healthcare technology indicate growing demand for cloud-based solutions, which Veeva is well-positioned to capitalize on.

Key Risk

If Veeva's revenue growth falls short of expectations, it could challenge the bullish consensus.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The market is debating whether Veeva can maintain its growth momentum in a competitive healthcare technology landscape.

Bull Confirmed If

Exceeding $2.14 in EPS and showing revenue growth above $858M would confirm the bull case.

Bear Confirmed If

Falling below the consensus EPS of $2.14 and revenue of $858M would confirm the bear case.

Pre-Earnings Positioning

Options Market

Implied Move

±12.28%

Historical Avg

±1.6%

Pricing rich

The options market is pricing in a significant move, suggesting that traders expect volatility around the earnings announcement.

Options are pricing ±12.3% while VEEV has averaged ±1.6% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.8%

30d HV

46.3%

Calls (61K)P/C Ratio: 0.38Puts (84K)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Veeva beats expectations, history suggests the stock could rise by around 2.89%, confirming strong demand and operational efficiency.

In-Line / Cautious

An in-line report may lead to a muted reaction, as investors assess management's commentary and future outlook.

Miss

If Veeva misses expectations, the stock could decline, with history suggesting an average drop of around 0.51%.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Updates on new product launches and their expected impact on revenue.
2Any commentary on customer acquisition and retention rates.
3Insights into competitive pressures in the healthcare technology sector.
4Management's outlook on market trends and how Veeva plans to adapt.
5Details on R&D investments and their anticipated outcomes.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

Jun1

SAICBMO

Science Applications International Corporation

PreviewView

Jun1

CRDOAMC

Company Snapshot

Veeva Systems Inc. is a healthcare technology company that provides cloud-based software solutions for the life sciences industry....

Key Metrics to Watch

EPS

Earnings per share is a key indicator of profitability and will show how well Veeva is managing costs and generating income.

$2.14

Revenue

Revenue growth is crucial for assessing the company's ability to expand its market share and maintain its competitive edge.

$858M

Wall Street expectations, options signals, track record, and call prep available with Pro.

VEEV Q1-2027 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

100%

Avg EPS Surprise

+60.26%

Avg Stock Reaction

-0.51%

Last Quarter Recap

In the last quarter, Veeva reported an EPS of $2.06, significantly beating analyst expectations. The stock reacted positively, gaining 1.38% the following day.

Management Promises & Guidance

Continued focus on expanding their product offerings.
Commitment to enhancing customer experience through technology.
Plans to invest in research and development to drive innovation.

Expectations

Wall Street Expectations

Bull Case

If Veeva exceeds expectations, it could signal robust demand for its products and lead to increased investor confidence, potentially driving the stock price higher.

Bear Case

Conversely, if the company fails to meet the consensus estimates, it could raise concerns about its growth trajectory and lead to a decline in stock price.

Key Metrics to Watch

EPS

$2.14

Earnings per share is a key indicator of profitability and will show how well Veeva is managing costs and generating income.

Revenue

$858M

Revenue growth is crucial for assessing the company's ability to expand its market share and maintain its competitive edge.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will Veeva's EPS exceed the consensus estimate of $2.14?

A beat on EPS would reinforce the company's strong performance trend and could lead to a positive market reaction.

What are the revenue projections for the upcoming quarters?

Revenue guidance will be crucial for understanding the company's growth trajectory and market demand.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may underestimate Veeva's ability to innovate and capture market share, especially given its strong track record of beating EPS estimates.

Supporting Evidence

Veeva has consistently exceeded EPS expectations in recent quarters, indicating strong operational performance.

The options market is pricing in a larger move than historical averages, suggesting traders expect significant volatility.

Recent trends in healthcare technology indicate growing demand for cloud-based solutions, which Veeva is well-positioned to capitalize on.

Key Risk

If Veeva's revenue growth falls short of expectations, it could challenge the bullish consensus.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The market is debating whether Veeva can maintain its growth momentum in a competitive healthcare technology landscape.

Bull Confirmed If

Exceeding $2.14 in EPS and showing revenue growth above $858M would confirm the bull case.

Bear Confirmed If

Falling below the consensus EPS of $2.14 and revenue of $858M would confirm the bear case.

Pre-Earnings Positioning

Options Market

Implied Move

±12.28%

Historical Avg

±1.6%

Pricing rich

The options market is pricing in a significant move, suggesting that traders expect volatility around the earnings announcement.

Options are pricing ±12.3% while VEEV has averaged ±1.6% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.8%

30d HV

46.3%

Calls (61K)P/C Ratio: 0.38Puts (84K)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Veeva beats expectations, history suggests the stock could rise by around 2.89%, confirming strong demand and operational efficiency.

In-Line / Cautious

An in-line report may lead to a muted reaction, as investors assess management's commentary and future outlook.

Miss

If Veeva misses expectations, the stock could decline, with history suggesting an average drop of around 0.51%.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Updates on new product launches and their expected impact on revenue.
2Any commentary on customer acquisition and retention rates.
3Insights into competitive pressures in the healthcare technology sector.
4Management's outlook on market trends and how Veeva plans to adapt.
5Details on R&D investments and their anticipated outcomes.